Semaglutide Pill Shows Heart Benefits in One Key Group, Study Finds : ScienceAlert

Taking oral semaglutide may reduce heart-related hospitalizations and deaths among those with a history of heart failure and type 2 diabetes, a new analysis suggests.

Data from a trial funded by Novo Nordisk – which produces the…

Continue Reading


News Source: www.sciencealert.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *